Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.400
-0.015-3.61%
Volume:103.00K
Turnover:42.06K
Market Cap:247.20M
PE:-0.95
High:0.410
Open:0.410
Low:0.400
Close:0.415
52wk High:5.400
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.41
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.420
ROE:-242.61%
ROA:-20.57%
PB:-2.52
PE(LYR):-0.95
PS:- -

Loading ...

Unexpected Surge: Moderna Jumps 177% on Historic Cancer Vaccine Breakthrough, Sending ASX and Hong Kong Biotech Stocks Soaring

Deep News
·
Aug 20

The Real Market Driver Right Now Might Surprise You

Deep News
·
Aug 20

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Stock News
·
Aug 20

Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?

Deep News
·
Aug 20

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

Stock News
·
Aug 19

This Sector Is Experiencing a Major Surge

Deep News
·
Aug 19

What We're Really Talking About When We Discuss Innovative Drugs Today

Deep News
·
Aug 19

Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?

Deep News
·
Aug 19

Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage

Stock News
·
Aug 18

Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials

Stock News
·
Aug 18

Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof

Deep News
·
Aug 16

Three Major Cross-Border Deals Land on Same Day, Boosting Sentiment for Chinese Innovative Drug Outbound Licensing; T+0 Huatai Baorui Hang Seng Innovative Drug ETF (520500) Attracts Over 2.5 Billion Yuan in Net Inflows Over the Past Year

Deep News
·
Aug 13

Three Emerging Export Sectors: How Many Does Nanjing Jiangbei New Area Command?

Deep News
·
Aug 12

Yiling Receives Notice for Clinical Trial Application of Its New Chemical Drug 'LB220-D08 Extended-Release Tablets'

Stock News
·
Aug 12

Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet

Stock News
·
Aug 12

Expanding Overseas, Earnings Validation, and AI Integration: China's Innovative Drug Sector Continues Its Recovery, with T+0 Huatai-PineBridge Hang Seng Innovation Drug ETF (520500) Seeing 77% Growth in Shares This Year

Deep News
·
Aug 12

Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend

Deep News
·
Aug 12

New Drug Popular Stock Surges to Daily Limit in 2 Minutes

Deep News
·
Aug 12

IMMUNOTECH-B Schedules 21 Aug 2026 Board Meeting to Approve 1H26 Interim Results

Bulletin Express
·
Aug 11

Immunotech Biopharm Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 11